Searched over 200M research papers
9 papers analyzed
These studies suggest that cancer incidence and survival rates vary significantly by type, with lung, liver, and stomach cancers being the most deadly, while prostate and thyroid cancers have the best survival rates, and treatment approaches often require a multidisciplinary strategy.
20 papers analyzed
Cancer in individuals aged 15 to 29 years is relatively rare, accounting for just 2% of all invasive cancers. However, the types of cancer that occur in this age group are distinct. The most common cancers include Hodgkin lymphoma, melanoma, testis cancer, female genital tract malignancies, thyroid cancer, soft-tissue sarcomas, non-Hodgkin lymphoma, leukemia, brain and spinal cord tumors, breast cancer, bone sarcomas, and nongonadal germ cell tumors, which together account for 95% of cancers in this demographic.
The incidence of cancer in this age group has increased steadily over the past 25 years but is now showing signs of decline. Males are at a higher risk of developing cancer, and non-Hispanic whites have the highest risk among ethnic groups. Survival rates have not improved significantly for older adolescents and young adults, with males and certain ethnic groups, such as African-Americans and American Indian/Alaska Natives, experiencing worse prognoses.
Globally, the most frequently diagnosed cancers are lung, breast, and prostate cancers, with lung cancer being the most deadly. By 2030, thyroid cancer is expected to become the fourth most common cancer diagnosis, while pancreas and liver cancers are projected to become the second and third leading causes of cancer-related deaths, respectively .
Cancer is the second leading cause of death worldwide, with lung, liver, and stomach cancers being the most lethal. Prostate and thyroid cancers have the best prognosis, with nearly 100% 5-year survival rates, whereas esophagus, liver, and pancreas cancers have the worst prognosis, with survival rates typically below 20% at 5 years.
Recent genomic analyses have identified 11 major molecular subtypes of cancer, some of which span multiple tissue types. For example, lung squamous, head and neck, and a subset of bladder cancers share common molecular features, such as TP53 alterations and high expression of immune and proliferation pathway genes. This molecular classification provides additional information for predicting clinical outcomes beyond traditional tissue-of-origin classifications.
Breast cancer is a heterogeneous disease with multiple histological subtypes, each associated with distinct biological features and clinical behaviors. Special types of breast cancer, such as secretory carcinomas and adenoid cystic carcinomas, have unique genetic alterations that influence their behavior and response to treatment. Understanding these subtypes can help identify novel therapeutic targets.
NSCLC is the most prevalent type of lung cancer and is primarily caused by smoking. It includes subtypes such as squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Treatment typically involves a combination of surgery, radiation, and chemotherapy, with a strong emphasis on early diagnosis and smoking cessation.
Head and neck cancers are diverse and primarily consist of squamous cell carcinomas. Major risk factors include tobacco use, alcohol abuse, and oncogenic viruses like HPV and Epstein-Barr virus. Treatment requires a multidisciplinary approach, including surgery, radiotherapy, and systemic therapy.
Endometrial cancer is classified into two main types: Type I, which is estrogen-driven and associated with obesity, and Type II, which is not strongly linked to these factors. Recent molecular studies have identified four distinct subtypes based on genetic mutations and histology, providing a more nuanced understanding of the disease.
Understanding the diverse types of cancer, their incidence, and molecular characteristics is crucial for improving diagnosis, treatment, and survival outcomes. Advances in genomic and histological analyses are paving the way for more personalized and effective cancer therapies.
Most relevant research papers on this topic